NX Prenatal Enters Collaboration to Develop High Throughput Clinical Mass Spec Proteomic Assays for NeXosome® Platform
LOUISVILLE, Ky., April 5, 2019 /PRNewswire/ — NX Prenatal Inc. (“NX Prenatal”) today announced that it…
LOUISVILLE, Ky., April 5, 2019 /PRNewswire/ — NX Prenatal Inc. (“NX Prenatal”) today announced that it…
BOSTON, April 5, 2019 /PRNewswire/ — “Congratulations to Amazon. Their news about Alexa and HIPAA…
WILSONVILLE, Ore. and FLORENCE, Italy, April 5, 2019 /PRNewswire/ — WaveForm Technologies Inc. a wholly owned…
TORONTO, April 5, 2019 /PRNewswire/ — QuadraNet has, over the past 19 years, established a distribution…
ALBANY, N.Y., April 5, 2019 /PRNewswire/ — DataGen, a leading healthcare data analytics and policy firm,…
SAN FRANCISCO, April 5, 2019 /PRNewswire/ — Hagens Berman Sobol Shapiro LLP alerts investors in…
SAN DIEGO, April 5, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology…
RESTON, Va., April 5, 2019 /PRNewswire/ — The new American College of Radiology (ACR) Data Science…
JACKSONVILLE, Fla., April 4, 2019 /PRNewswire/ — Wellbox, a technology enabled chronic disease care management…
SAN FRANCISCO, April 4, 2019 /PRNewswire/ — Non-clinical factors can account for up to 80 percent…